We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rare Hereditary Autoimmune Disease Found to Have More Common Form

By LabMedica International staff writers
Posted on 21 Jun 2015
Print article
Image: Illustrated summary of the role of the AIRE gene product and its connection to a group of autoimmune disorders now discovered to be related. The AIRE gene is expressed in a rare population of the thymus, where it is critical for educating immune cells, called T cells, to discriminate between foreign invaders and body’s own proteins. Normally (top) AIRE operates in the form of a complex made up of four identical strands. When both copies of the AIRE gene are mutated (recessive), the resulting complex (middle) is dysfunctional and patients suffer from severe autoimmune disorders. When there are specific mutations in only one copy (dominant, bottom), the protein\'s function can still be disrupted and individuals can develop autoimmune disorders with different levels of severity. (Photo courtesy of Weizmann Institute of Science).
Image: Illustrated summary of the role of the AIRE gene product and its connection to a group of autoimmune disorders now discovered to be related. The AIRE gene is expressed in a rare population of the thymus, where it is critical for educating immune cells, called T cells, to discriminate between foreign invaders and body’s own proteins. Normally (top) AIRE operates in the form of a complex made up of four identical strands. When both copies of the AIRE gene are mutated (recessive), the resulting complex (middle) is dysfunctional and patients suffer from severe autoimmune disorders. When there are specific mutations in only one copy (dominant, bottom), the protein\'s function can still be disrupted and individuals can develop autoimmune disorders with different levels of severity. (Photo courtesy of Weizmann Institute of Science).
Image: Simplified view of AIRE protein functionality versus autoimmunity, depending on double- or single-allele AIRE gene mutations (Photo courtesy of Oftedal BE et al., June 2015, in Immunity).
Image: Simplified view of AIRE protein functionality versus autoimmunity, depending on double- or single-allele AIRE gene mutations (Photo courtesy of Oftedal BE et al., June 2015, in Immunity).
Researchers have discovered that single-allele mutations in the gene that causes recessive autoimmune polyendocrine syndrome type-1 (APS-1) can cause a less severe but more common condition. Findings may help identify, diagnose, and treat a number of autoimmune diseases.

APS-1, caused by recessive (double-allele) mutation in the AIRE (AutoImmune REgulator) gene, is a constellation of medical problems ranging from attack on and destruction of multiple tissues and organs, to chronic infections. According to the new study, led by Dr. Jakub Abramson of the Weizmann Institute of Science (Rehovot, Israel) and Dr. Eystein S. Husebye of the University of Bergen (Bergen, Norway), APS-1 was thought to be exceedingly rare but now appears to have a less severe form that affects at least 1 in 1,000 people. Their results suggest that a number of autoimmune disorders may be linked to mutations in AIRE.

AIRE normally prevents such autoimmune attacks by overseeing the training of immune cells to ignore self-made antigens. AIRE is almost exclusively expressed in the thymus, where T-cells undergo a “basic training” before being released into the bloodstream for defense missions. In the thymus, AIRE operates in medullary thymic epithelial cells (mTECs), which act as “examiners,” checking that released T-cells will not react to self-antigens. mTECs create a comprehensive genomic expression library of self-antigens and test T-cells for their reactions—T-cells that attack a self-antigen are eliminated in the thymus. AIRE controls the expression of the thousands of self-antigen genes within the thymus. In another recent study (Nature Immunology), Dr. Abramson’s group discovered that AIRE is itself regulated by SIRT1, present at exceptionally high levels in mTECs and keeps AIRE activated.

Current medical wisdom assumes that clinical symptoms will arise only if both AIRE alleles are dysfunctional. Dr. Abramson and Dr. Husebye challenged this widely accepted notion and found that even a single-allele mutation may disrupt function and cause devastating autoimmunity. AIRE proteins bind one another, forming an active complex. A specific mutation in one copy is enough to disrupt function of the entire complex in a dominant-like manner.

The study arose from an unusual clinical observation in Dr. Husebye’s lab where a patient had an autoimmune syndrome suggesting recessive AIRE mutations, but was revealed to be mutated in only one allele. Among the patient’s children: those carrying the single-allele mutation had also developed an autoimmune disorder, but it was milder and did not match the symptoms of the recessive syndrome. Drs. Abramson and Husebye hypothesized that such dominant AIRE mutations may be a common cause of autoimmune disorders. The two research groups performed lab experiments and examined medical data from families in Norway, Finland, and Russia who suffered from various forms of autoimmunity. They found that many of those with single-allele AIRE mutations had been diagnosed with various autoimmune disorders.

“A dominant AIRE malfunction could explain the mechanism of a number of autoimmune diseases,” said Dr. Abramson. Further research revealed that only mutations at certain sites of the AIRE gene confer dominance over the healthy gene. Interestingly, however, the healthy gene is not completely negated: The dominant version of the disease is less severe, appears later in life, and may affect fewer organs than in APS-1.

The study, by Oftedal BE et al., was published June 16, 2015, in the journal Immunity.

Related Links:

Weizmann Institute of Science
University of Bergen


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Blood Gas and Chemistry Analysis System
Edan i500

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.